-
3-D Bio Modeling, Illustration Software Designed
2 December 2014. Researchers at Scripps Research Institute in La Jolla, California developed cellPack, software that makes it possible to model and visualize biological matter in three dimensions between the levels of molecules and cells. The open-source software from the lab of Scripps computational biologist Arthur Olson is described in a paper published online yesterday…
-
AstraZeneca, Lilly Begin Alzheimer’s Drug Trial
1 December 2014. The pharmaceutical companies AstraZeneca and Eli Lilly and Company began enrolling patients in a clinical trial testing an experimental treatment for Alzheimer’s disease. The intermediate and late-stage trial aims to recruit some 1,550 patients in 15 countries to test safety and effectiveness of the drug code-named AZD3293 against a placebo with patients…
-
Genome Editing Company Licenses University Technologies
1 December 2014. Editas Medicine, a Cambridge, Massachusetts start-up, licensed technologies developed by the company’s scientific founders and others that allow for editing the human genome to create new therapies. Financial terms of the exclusive licensing deals with Harvard University, MIT, Massachusetts General Hospital, and Duke University were not disclosed. Editas Medicine, founded in 2013,…
-
Report from Turkey: Transformation to Ignorance
A visit to a high school for science in Turkey reveals a plan by Turkey’s government to shut down a tutoring program for low-income children, apparently to punish political rivals. 25 November 2014. President Recep Tayyip Erdogan (pronounced AIR-doo-wan) of Turkey made news this month, when he told a meeting of visiting Islamic clergy from…
-
Coming Up: Reports from Turkey
13 November 2014. Science & Enterprise will be on the road for the next two weeks, on a press and study tour of Turkey, where we hope to report on initiatives involving entrepreneurship and research in this vital and sensitive part of the world. We expect to have fewer posts through the rest of November,…
-
Human Longevity Accessing Twins Genomic Database
13 November 2014. Human Longevity Inc., a bioinformatics and genomics company for solving age-related medical problems, is getting access to a database of genome and gut microbe samples from twins in the U.K. to provide a broader analytical base for designing new diagnostics and therapies. Financial details of the agreement between the San Diego company founded…
-
Cardiologists, Incubator Partner on Health Challenge
13 November 2014. American College of Cardiology is taking part in an international challenge to find start-ups developing breakthrough technologies, sponsored by 1776, an incubator and investment fund in Washington, D.C. The Challenge Cup, as the competition is called, takes place in 16 cities in 11 countries, with a total prize package of $650,000. Challenge…
-
Type 2 Diabetes Technology Licensed in $1 Billion Deal
12 November 2014. Intarcia Therapeutics Inc., developing a drug and delivery mechanism to treat type 2 diabetes, licensed its technology to the pharmaceutical company Servier in a deal with a potential value of $1 billion. The agreement gives Servier exclusive rights to Intarcia’s diabetes treatment technology to regions outside of the U.S. and Japan. Intarcia’s…
-
Trial Shows Engineered Antibody Relieves Psoriasis
11 November 2014. A late-stage clinical trial shows a monoclonal antibody, a type of engineered biological therapy, cleared more people of the skin condition plaque psoriasis than a placebo or a competitive treatment. The biologic drug, brodalumab, is developed by the biotechnology company Amgen and pharmaceutical maker AstraZeneca. Plaque psoriasis is the most common type…
-
Takada Pharma, GE Healthcare to Partner on Liver Disease
11 November 2014. Takada Pharmaceutical Company and GE Healthcare are collaborating on research into scarring of liver tissue that happens when damage occurs, often from fat building up in the liver, an increasingly common condition. Financial terms of the partnership, announced today at a meeting of American Association for the Study of Liver Diseases in Boston,…